Annabelle Pfeifle

Ottawa, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Durability of DNA-LNP and mRNA-LNP vaccine-induced immunity against SARS-CoV-2 XBB.1.5.

Durability of DNA-LNP and mRNA-LNP vaccine-induced immunity against SARS-CoV-2 XBB.1.5.

Journal: NPJ vaccines
Published: October 15, 2025

Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses.

Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses.

Journal: Antiviral research
Published: August 05, 2025

Polyvalent mRNA vaccine targeting outer surface protein C affords multi-strain protection against Lyme disease.

Polyvalent mRNA vaccine targeting outer surface protein C affords multi-strain protection against Lyme disease.

Journal: NPJ vaccines
Published: July 15, 2025

Borrelia burgdorferi Strain-Specific Differences in Mouse Infectivity and Pathology.

Borrelia burgdorferi Strain-Specific Differences in Mouse Infectivity and Pathology.

Journal: Pathogens (Basel, Switzerland)
Published: March 07, 2025

Erratum: Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters.

Erratum: Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters.

Journal: Molecular therapy. Methods & clinical development
Published: January 06, 2025

Dissecting immunological mechanisms underlying influenza viral nucleoprotein-induced mucosal immunity against diverse viral strains.

Dissecting immunological mechanisms underlying influenza viral nucleoprotein-induced mucosal immunity against diverse viral strains.

Journal: Emerging microbes & infections
Published: November 07, 2024

Novel recombinant vaccinia virus-vectored vaccine affords complete protection against homologous Borrelia burgdorferi infection in mice.

Novel recombinant vaccinia virus-vectored vaccine affords complete protection against homologous Borrelia burgdorferi infection in mice.

Journal: Emerging microbes & infections
Published: September 02, 2024

Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters.

Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters.

Journal: Molecular therapy. Methods & clinical development
Published: March 21, 2024

Assessing fecal metaproteomics workflow and small protein recovery using DDA and DIA PASEF mass spectrometry.

Assessing fecal metaproteomics workflow and small protein recovery using DDA and DIA PASEF mass spectrometry.

Journal: Microbiome research reports
Published: March 15, 2024

The Expression Kinetics and Immunogenicity of Lipid Nanoparticles Delivering Plasmid DNA and mRNA in Mice.

The Expression Kinetics and Immunogenicity of Lipid Nanoparticles Delivering Plasmid DNA and mRNA in Mice.

Journal: Vaccines
Published: July 31, 2023

Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses.

Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses.

Journal: Emerging microbes & infections
Published: March 17, 2023

DNA lipid nanoparticle vaccine targeting outer surface protein C affords protection against homologous Borrelia burgdorferi needle challenge in mice.

DNA lipid nanoparticle vaccine targeting outer surface protein C affords protection against homologous Borrelia burgdorferi needle challenge in mice.

Journal: Frontiers in immunology
Published: August 15, 2022
Showing 1-12 of 16

Last Updated: 09/26/2026